Delivery Order SPE2DB24D2205-SPE2DB25FEFDX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $31,549.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical delivery to support federal medical procurement needs. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $5,747.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,593.34 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $16,247.74. The order was competitively awarded without set-aside provisions and has an ultimate completion date of July 23, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,546.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $17,178.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60 count) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFDXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,278.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is the performance location for this delivery order. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical program utilizes such prime vendor contracts to efficiently fulfill pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions with multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.3k | 7/21/25 |